Pharma Focus America
ThermoFisherScientific - Custom and Bulks

News

Are you looking for recent Pharma Magazine information?
Check out the Top News in Pharma Magazine, Leading Magazine in the Pharma Industry, and most recent pharmaceutical news. Daily information updates related to the industrial sectors we work in are presented in the pharmaceutical industry's news area

Gyros Protein Technologies Launches Gyrolab Generic Anti-AAV Kit to Propel Gene Therapy Innovation

Tuesday, June 18, 2024

Gyros Protein Technologies AB known for its pioneering work in automated nanoliterscale immunoassays and peptide synthesizers has introduced the Gyrolab Generic AntiAdeno Associated Virus

Adalvo Receives Initial EU Approval for Generic Liraglutide Prefilled Pen

Monday, June 17, 2024

Adalvo has announced the successful approval of the liraglutide prefilled pen under the EUs DCP marking a milestone as the first generic drug approval in the region According to IQVIA reports this peptide drug a bioequivalent of the Victoza prefilled...

Jumpcode Genomics and Takara Bio USA Establish Worldwide Patent Collaboration

Friday, June 14, 2024

Jumpcode Genomics a company specializing in genomic technologies and Takara Bio USA Inc a subsidiary of Takara Bio Inc have ended their patent dispute and agreed to collaborate This partnership focuses

Santa Ana Bio Launches with $168 Million for Advancing Precision Medicines in Inflammatory Diseases

Friday, June 14, 2024

Santa Ana Bio a company specializing in precision immunology has publicly launched with million in funding from Series A and B rounds The Series A funding round was led by Versant Ventures

Allay Therapeutics Gets FDA Approval for IND Application to Launch Phase 2B Study of ATX101 for Treating Pain After Knee Surgery

Thursday, June 13, 2024

Allay Therapeutics a clinicalstage biotechnology company has announced its intention to advance to a Phase b registration trial for its leading investigational product ATX This trial will be based on solid data

KSQ Therapeutics Launches Clinical Trial for KSQ-001EX, a CRISPR/Cas9 Modified Tumor Infiltrating Lymphocyte Therapy

Thursday, June 13, 2024

KSQ Therapeutics Inc a clinicalstage biotechnology firm dedicated to developing treatments for solid tumors has commenced the first patient in its Phase clinical trial for KSQEX an innovative

InnoCare Receives FDA Clearance for Clinical Trial of TYK2 Inhibitor ICP-332

Wednesday, June 12, 2024

InnoCare Pharma a leading biopharmaceutical company focused on treatments for cancer and autoimmune disorders has received approval from the US Food and Drug Administration for the Investigational New Drug application for its new TYK

Eilean Therapeutics Partners with the Leukemia & Lymphoma Society for the Beat AML® Master Clinical Trial

Wednesday, June 12, 2024

Eilean Therapeutics AU Pty Ltd a biopharmaceutical firm committed to developing advanced small molecule inhibitors for hematologic and solid cancers has partnered with The Leukemia Lymphoma Society

Myriad Genetics and GSK Team Up to Broaden Access to HRD Testing in Nine Countries

Wednesday, June 12, 2024

Myriad Genetics Inc a leader in genetic testing and precision medicine has announced a partnership with GSK to improve access to homologous recombination deficiency diagnostic testing for patients

TAGRISSO® (Osimertinib) Granted Priority Review for Stage III EGFR-Mutated Lung Cancer Treatment in the US

Tuesday, June 11, 2024

AstraZeneca has submitted a supplemental New Drug Application for TAGRISSO which has been accepted for Priority Review by the FDA This application seeks approval for TAGRISSO

Thermo Fisher Scientific viral vector services (VVS)Future Labs Live USA 2024patheon - Mastering API production at every scaleWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Advanced Therapies USA 2024World Orphan Drug Congress Europe 2024